A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator Controlled Trial of Flexible-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Trial Profile

A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator Controlled Trial of Flexible-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Mar 2017

At a glance

  • Drugs Brexpiprazole (Primary) ; Quetiapine
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Acronyms Delphinus
  • Sponsors Otsuka Pharmaceutical Development & Commercialization
  • Most Recent Events

    • 29 Nov 2016 Status changed from recruiting to completed.
    • 29 Oct 2016 This trial was completed in France (end date: 2016-10-15), according to European Clinical Trials Database.
    • 28 Oct 2016 This trial has been completed in Germany (end date: 2016-10-15), according to European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top